Douglas Johnson Archive — Page 1 of 2

June 15, 2026

People Transforming the Cancer Center

Spotlighting the people of Vanderbilt Ingram Cancer Center

June 15, 2026

New Therapy

Patient with melanoma receives tumor-infiltrating lymphocyte therapy

February 18, 2026

Patient with melanoma receives tumor-infiltrating lymphocyte therapy

The highly personalized treatment is currently approved for patients with advanced stages of melanoma whose tumors have grown despite immunotherapies and/or targeted therapies.

November 12, 2025

Eleven Vanderbilt scientists among this year’s ‘highly cited’ researchers

They are among 6,868 scientists worldwide whose papers rank in the top 1% by citations for their fields of research and publication year in the Web of Science Core Collection over the past 11 years.

The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)
September 10, 2025

Vanderbilt-Ingram Cancer Center names associate directors and new program leaders 

Shared resources at Vanderbilt-Ingram are designed to support and enhance cancer-relevant research and scientific interaction by providing access to cutting-edge technologies and services, as well as scientific expertise.

(iStock image)
April 10, 2025

Study provides guidance on immunotherapy-related, chronic skin reactions 

Researchers recommended long-term follow-up for patients by dermatologists familiar with cirAEs and consideration of corticosteroid-sparing treatment options.